News / Taiwan / economic_daily
TWSE Fines Guangli-KY NT$50,000 for Delayed Financial Disclosure
Health Technology · Biotechnology · economic_daily · 2026-08-25
6431
Guangli-KY has been fined NT$50,000 by the Taiwan Stock Exchange for failing to timely disclose information regarding its second-quarter financial report board meeting.
What Happened
Violation Details: Guangli-KY failed to timely disclose a material event regarding its board meeting scheduled for August 26, 115, to approve the second-quarter financial results. The company was expected to report this information by August 19 but missed the regulatory deadline.
Regulatory Penalty: The Taiwan Stock Exchange (TWSE) determined that the company breached Article 4, Paragraph 1, Subparagraph 31 of the Procedures for Verification and Disclosure of Material Information. Consequently, the exchange imposed a fine of NT$50,000 on the company.
Compliance Mandate: The TWSE has issued a formal notice to Guangli-KY, mandating that the company improve its internal procedures. The exchange emphasized that future disclosures must strictly adhere to regulatory requirements to ensure market transparency.
Market Impact: While the financial penalty is relatively minor, it highlights the importance of corporate governance and timely reporting for listed companies. Investors are advised to monitor the company's future compliance efforts and the accuracy of its financial reporting processes.
Read original
More in Health Technology
Health Technology · economic_daily · 2026-08-25
Taiwan stocks retreated as investors braced for Nvidia's earnings and Fed commentary, while biotech firm Pei-Er Biomedical bucked the trend to reach a new record.
2059, 3231, 5274, 6446, 6949
Health Technology · yonhap_finance · 2026-08-24
DS Investment Securities raised Hanmi Pharmaceutical's target price to 720,000 KRW, citing increased clinical success potential following a major licensing deal.
128940
Health Technology · economic_daily · 2026-08-24
PharmaEssentia's innovative interferon Ropeg has received approval from Japan's MHLW for the treatment of essential thrombocythemia, covering all patient segments.
6446
Latest in Taiwan
Electronic Technology · economic_daily · 2026-08-25
The Taiwan Stock Exchange will collaborate with Fubon Securities to host a series of earnings presentations and industry seminars at SEMICON Taiwan on September 3rd, featuring seven listed companies and expert insights.
3583, 4770, 5434, 6854, 7610, 7730, 7823
Finance · economic_daily · 2026-08-25
The Taiwan Stock Exchange has approved major regulatory changes, including reducing the tick size for stocks over NT$1,000 to NT$1 and extending the monitoring period for defaulting investors to five years.
Finance · economic_daily · 2026-08-25
Foreign investors increased their net short positions in TAIEX futures to over 85,000 contracts while rotating into financial stocks and trimming holdings in semiconductors and ETFs.
00403, 00407, 0050, 00631, 00981
Electronic Technology · economic_daily · 2026-08-25
The Taiwan Stock Exchange will feature four innovative semiconductor companies at its 'Innovative Board' pavilion during SEMICON Taiwan 2026 to boost global visibility.
6842, 7887, 7913